Brief: Zim Laboratories Gets Marketing Authorization For Buprenorphine Sublingual Film In Europe
10/01/2025 12:58
Jan 10 (Reuters) - Zim Laboratories Ltd ZIML.NS :
* ZIM LABORATORIES- GRANT OF MARKETING AUTHORIZATION FOR
BUPRENORPHINE SUBLINGUAL FILM IN EUROPE
Source text: ID:nNSE4RLMTX
Further company coverage: ZIML.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia